Quarter-Sized implant could free type 1 diabetes patients from daily insulin
Disease control
Not yet recruiting
This early-stage trial tests a small, soft implant that holds donor insulin-making cells (islets) and protects them from the immune system. The goal is to see if the device is safe and keeps the cells alive and working in adults with type 1 diabetes. Some participants are also on…
Phase: PHASE1 • Sponsor: Encellin • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC